Brief: Genor Biopharma, Its Unit & Edding Group Entered Into Merger Agreement
Oct 7 (Reuters) - Genor Biopharma Holdings Ltd
6998.HK :
* ON 13 SEPT CO ENTERED INTO MERGER AGREEMENT
* CO, EDDING GROUP COMPANY AND UNIT ENTERED INTO MERGER
AGREEMENT
* CO WILL ACQUIRE EDDING GROUP COMPANY BY WAY OF MERGER
* CONSIDERATION OF PROPOSED MERGER IS TO BE WHOLLY SETTLED
BY WAY
OF ISSUING CONSIDERATION SHARES
* UNIT GENEDD WILL BE MERGED WITH AND INTO EDDING
Further company coverage: 6998.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edding Genor group
See all newsBrief: JHBP CY Says Chairman And CEO Ni Xin To Buy Shares Up To USD 1 Million From Aug 31, 2026
Brief: Edding Genor Group Expects Revenue Of RMB850 MLN-RMB900 MLN For HY
Brief: Jhbp Cy Disposal Of Equity Interest In Candid Therapeutics
Edding Genor climbs on approval of clinical trial of cancer drug in China
Brief: JHBP CY's Phase Ib/Ii Clinical Trial Of Gb268 Obtains IND Approval By NMPA